Dennis A. Holt,Juan I. Luengo,Dennis S. Yamashita,Hye-Ja Oh,Arda L. Konialian,Hwa-Kwo Yen,Leonard W. Rozamus,Martín Brandt,Mary J. Bossard,Mark A. Levy,Drake S. Eggleston,Jack Liang,L. Wayne Schultz,Thomas J. Stout,Jon Clardy
The design and synthesis of high-affinity FKBP12 ligands is described. These compounds potently inhibit the cis-trans-peptidylprolyl isomerase (rotamase) activity catalyzed by FKBP12 with inhibition constants (K i,app ) as low as 1 nM, yet they possess remarkable structural simplicity relative to FK506 and rapamycin, from which they are conceptually derived. The atomic structures of three FKBP12-ligand complexes and of one unbound ligand were determined by X-ray crystallography and are compared to the FKBP12-FK506 and FKBP12-rapamycin complexes